Vimarsana
Biggest News Aggregation in the World

Al0891 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Al0891. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Al0891 Today - Breaking & Trending Today

Press Release: Basilea reports preclinical data on oncology drug candidates BAL0891, derazantinib and lisavanbulin at AACR Annual Meeting - Vimarsana News

Press Release: Basilea reports preclinical data on oncology drug candidates BAL0891, derazantinib and lisavanbulin at AACR Annual Meeting

Basel, Switzerland, April 13, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer

Basilea Pharmaceutica AG: Basilea reports preclinical data on anti-cancer activity of novel oncology drug candidate BAL0891 at ESMO TAT congress - Vimarsana News

Basilea Pharmaceutica AG: Basilea reports preclinical data on anti-cancer activity of novel oncology drug candidate BAL0891 at ESMO TAT congress

Press Release Basel, Switzerland, March 08, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious

Basilea Pharmaceutica AG: Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891 - Vimarsana News

Basilea Pharmaceutica AG: Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891

Phase 1 study in patients with advanced solid tumors planned to start in the first quarter of 2022 Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 17, 2021 Basilea Pharmaceutica